PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway

[1] Siegel RL(2022)Cancer statistics, 2022 Cancer J Clin 72 7-33

[2] Miller KD(2018)Lung cancer screening, Version 3.2018, NCCN clinical practice guidelines in oncology J Natl Compr Cancer Netw. 16 412-441

[3] Fuchs HE(2021)Enhanced sensitivity of nonsmall cell lung cancer with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors to phenformin: the roles of a metabolic shift to oxidative phosphorylation and redox balance Oxid Med Cell Longev 2021 5428364-270

[4] Jemal A(1956)On respiratory impairment in cancer cells Science 124 269-538

[5] Wood DE(2021)Potentials of non-invasive (18)F-FDG PET/CT in immunotherapy prediction for non-small cell lung cancer Front Genet 12 518-663

[6] Kazerooni EA(2019)Emerging technologies to image tissue metabolism Cell Metab 29 659-5914

[7] Baum SL(2022)Signaling pathways that drive (18)F-FDG accumulation in cancer J Nucl Med 63 5907-248

[8] Eapen GA(2019)A tumor agnostic therapeutic strategy for hexokinase 1-Null/Hexokinase 2-positive cancers Can Res 79 240-195

[9] Ettinger DS(2021)Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics Cancer Lett 503 184-31

[10] Hou L(2022)Role of LDH in tumor glycolysis: regulation of LDHA by small molecules for cancer therapeutics Semin Cancer Biol 87 25-88

[1] Siegel RL(2022)Cancer statistics, 2022 Cancer J Clin 72 7-33

[2] Miller KD(2018)Lung cancer screening, Version 3.2018, NCCN clinical practice guidelines in oncology J Natl Compr Cancer Netw. 16 412-441

[3] Fuchs HE(2021)Enhanced sensitivity of nonsmall cell lung cancer with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors to phenformin: the roles of a metabolic shift to oxidative phosphorylation and redox balance Oxid Med Cell Longev 2021 5428364-270

[4] Jemal A(1956)On respiratory impairment in cancer cells Science 124 269-538

[5] Wood DE(2021)Potentials of non-invasive (18)F-FDG PET/CT in immunotherapy prediction for non-small cell lung cancer Front Genet 12 518-663

[6] Kazerooni EA(2019)Emerging technologies to image tissue metabolism Cell Metab 29 659-5914

[7] Baum SL(2022)Signaling pathways that drive (18)F-FDG accumulation in cancer J Nucl Med 63 5907-248

[8] Eapen GA(2019)A tumor agnostic therapeutic strategy for hexokinase 1-Null/Hexokinase 2-positive cancers Can Res 79 240-195

[9] Ettinger DS(2021)Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics Cancer Lett 503 184-31

[10] Hou L(2022)Role of LDH in tumor glycolysis: regulation of LDHA by small molecules for cancer therapeutics Semin Cancer Biol 87 25-88